| Karen Stitzenberg, MD | |
|
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
| (919) 966-4131 | |
| Not Available |
| Full Name | Karen Stitzenberg |
|---|---|
| Gender | Female |
| Speciality | Surgical Oncology |
| Experience | 24 Years |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023237229 | NPI | - | NPPES |
| 1020334890001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086X0206X | Surgery - Surgical Oncology | MD431191 (Pennsylvania) | Secondary |
| 208600000X | Surgery | 200301415 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.
Health-promotion and disease-prevention efforts can no longer use a one-size-fits-all approach. Efforts targeting emerging adult populations - encompassing late adolescence and early adulthood - must embrace and utilize multi-pronged, multi-media approaches in order to be successful.
The Obama administration announced Monday that it will revise substantially the five-star rating program for nursing homes.
› Verified 2 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.
Health-promotion and disease-prevention efforts can no longer use a one-size-fits-all approach. Efforts targeting emerging adult populations - encompassing late adolescence and early adulthood - must embrace and utilize multi-pronged, multi-media approaches in order to be successful.
The Obama administration announced Monday that it will revise substantially the five-star rating program for nursing homes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Stitzenberg, MD 143 W Franklin St, Suite #600, Chapel Hill, NC 27516-2539 Ph: (919) 966-4131 | Karen Stitzenberg, MD 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (919) 966-4131 |
News Archive
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.
Health-promotion and disease-prevention efforts can no longer use a one-size-fits-all approach. Efforts targeting emerging adult populations - encompassing late adolescence and early adulthood - must embrace and utilize multi-pronged, multi-media approaches in order to be successful.
The Obama administration announced Monday that it will revise substantially the five-star rating program for nursing homes.
› Verified 2 days ago
Dr. Felicia Nicole Williams, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-966-8159 Fax: 919-843-6568 | |
Daniel Taylor Mcmillan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Burnett Womack Building, Cb#7050, Chapel Hill, NC 27599 Phone: 919-966-4320 | |
Ruthann M Conoley, PHARM.D Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-8596 Fax: 919-843-5515 | |
Jeremiah Lee Deneve, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-0000 | |
Harry Marshall, Surgery Medicare: Accepting Medicare Assignments Practice Location: 4008 Burnett-womack Building, Campus Box 7228, Chapel Hill, NC 27599 Phone: 919-966-4389 | |
Ehsan Benrashid, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 |